TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioNema AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
338
|
292
|
229 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
100
|
28
|
29 |
| EBITDA |
105
|
34
|
38 |
| Total assets |
275
|
220
|
204 |
| Current assets |
114
|
181
|
162 |
| Current liabilities |
27
|
28
|
17 |
| Equity capital |
248
|
192
|
187 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.2%
|
87.3%
|
91.7% |
| Turnover per employee |
169
|
146
|
114 |
| Profit as a percentage of turnover |
29.6%
|
9.6%
|
12.7% |
| Return on assets (ROA) |
36.4%
|
12.7%
|
14.2% |
| Current ratio |
422.2%
|
646.4%
|
952.9% |
| Return on equity (ROE) |
40.3%
|
14.6%
|
15.5% |
| Change turnover |
56
|
62
|
-84 |
| Change turnover % |
20%
|
27%
|
-27% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.